YOLFTbeta
Savara Inc

Savara Inc

SVRA · NASDAQ · Healthcare / Biotechnology

4.64USD-0.08 (-1.69%)

Price History

Full chart

Market Stats

Previous Close4.72
Open4.80
Day Range4.58 – 4.85
52-Week Range3.34 – 7.01
Volume3.23M
Market Cap1.02B
P/E (TTM)0.00
Forward P/E0.41
EPS-0.58
Dividend Yield0.00%
Beta0.25
50-Day Avg5.45
200-Day Avg5.57

About

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Matthew Pauls J.D., M.B.A.
  • Employees70
  • HeadquartersThe Tannery Building, Yardley, PA, United States, 19067, USA
  • Websitehttps://www.savarapharma.com

Leadership

  • Mr. Matthew Pauls J.D., M.B.A.Chairman & CEO · b. 1971
  • Mr. Robert Matthew Lutz M.B.A.COO & CFO · b. 1969
  • Dr. Yasmine Wasfi M.D., Ph.D.Chief Medical Officer
  • Ms. Kate McCabe J.D.Chief Legal Officer · b. 1986
  • Ms. Megan CarpenterChief People Officer
  • Ms. Anne EricksonChief Business & Corporate Affairs Officer · b. 1972
  • Brian MaurerHead of Clinical Operations
  • Mr. Charles LaPreeExecutive VP & Head of Global Regulatory Affairs
  • Dr. Brian Robinson M.D.Executive Vice President of Global Medical Affairs
  • Dr. Siddharth J. Advant Ph.D.Executive Vice President of Global Technical Operations

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----496.06K-500.00K500.00K300.00K488.96K0001.55K54400.00K000257.00K1.00K0000
Growth (%)--------0.00%-40.00%+62.99%-100.00%----96.51%+740640.74%-100.00%----99.61%-100.00%---
Cost of Revenue-----------0000146.00K8.18M363.00K526.00K38.78M35.04M28.99M27.88M44.26M78.03M245.00K
Gross Profit-----496.06K-500.00K500.00K300.00K488.96K0001.55K-145.95K400.00K-363.00K-526.00K-38.78M-34.78M-28.99M-27.88M-44.26M-78.03M-245.00K
Gross Margin-----100.00%-100.00%100.00%100.00%100.00%---100.00%-270270.37%100.00%----13533.46%-2899100.00%----
Operating Expense-----13.70M-24.81M27.81M11.59M9.03M13.40M15.63M21.54M29.28M39.23M11.35M29.59M69.52M40.24M14.52M12.49M10.96M15.74M25.17M123.30M
Operating Income-3.72M-10.66M-2.10M-2.34M-6.80M-13.20M-29.84M-24.31M-27.31M-11.29M-8.54M-13.40M-15.63M-21.54M-29.28M-39.37M-10.95M-29.96M-70.05M-79.03M-49.30M-41.48M-38.84M-60.01M-103.20M-123.55M
Operating Margin------2661.58%--4862.21%-5461.97%-3761.89%-1746.51%----1891408.27%-72912962.96%-2737.00%----19182.88%-4147700.00%----
EBITDA-1.81M2.72M-1.72M-2.32M-6.66M-13.09M-29.16M-24.11M-27.14M-11.21M-8.43M-13.22M-15.47M-21.44M-28.62M-39.09M-10.48M-31.91M-69.50M-50.43M-45.85M-40.50M-38.01M-59.13M-102.27M-118.59M
EBITDA Margin------2638.28%--4822.65%-5428.36%-3735.32%-1723.96%----1848643.41%-72394444.44%-2620.50%----17841.25%-4049700.00%----
Net Income-3.70M-16.34M-2.11M-2.33M-6.70M-24.78M-29.33M-22.14M-26.65M-11.33M-8.45M-13.26M-15.56M-21.48M-28.70M-39.84M-10.92M-29.80M-61.52M-78.17M-49.62M-43.01M-38.15M-54.70M-95.88M-118.84M
Net Income Margin------4995.91%--4428.41%-5329.50%-3775.02%-1728.35%----1854134.37%-73781481.48%-2730.75%----19305.45%-4301400.00%----
R&D1.02M946.42K282.97K749.00K2.74M8.68M12.00M15.93M17.92M6.51M3.69M5.76M8.09M12.90M19.43M28.26M8.18M18.51M37.17M38.78M35.04M28.99M27.88M44.26M78.03M81.40M
R&D as % of Total Revenue-----1750.30%-3186.88%3584.44%2169.22%754.41%---1255490.96%52340740.74%2045.50%---13633.46%2899100.00%----
Interest Expense23.50K12.02K53.70K1.39K1.39K000001.63K11.01K000603.00K468.00K1.16M11.00K70.00K1.48M2.28M88.00K---
Interest Expense % of Total Revenue-----0.00%-0.00%0.00%0.00%0.33%---0.00%1116666.67%117.00%---576.65%228200.00%----

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.88M278.01K130.34K4.28M13.61M23.62M52.80M34.54M10.71M9.03M28.49M61.86M46.97M55.25M70.50M54.22M28.93M159.63M152.29M136.20M97.75M176.60M139.78M177.56M212.88M253.44M
Total Liabilities268.57K916.49K983.08K163.04K1.22M31.45M32.84M3.51M4.71M2.35M1.80M5.08M5.18M7.44M11.84M30.33M64.81M40.32M152.29M34.51M33.36M32.10M32.00M37.19M41.43M50.30M
Total Equity14.61M-638.49K-852.73K4.12M12.39M-7.83M19.96M31.03M6.00M6.67M26.69M56.78M41.79M47.81M58.66M23.89M-35.88M119.31M108.22M101.70M64.38M144.50M107.78M140.37M171.45M203.13M
Cash1.48M164.48K103.93K4.23M13.03M14.63M25.97M14.78M9.85M8.67M27.98M43.57M22.50M25.68M35.81M23.05M13.37M22.12M24.30M49.80M22.88M34.01M52.10M26.59M15.13M33.18M
Total Debt-54.44K253.95K------------14.74M4.47M15.34M24.57M25.55M25.28M25.79M26.14M26.49M26.73M29.91M
Net Debt-1.48M-110.04K150.02K-4.23M-13.03M-14.63M-25.97M-14.78M-9.85M-8.67M-27.98M-43.57M-22.50M-25.68M-35.81M-8.31M-8.90M-6.78M270.00K-24.25M2.40M-8.22M-25.96M-94.00K11.61M-3.27M

Cash Flow

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.15M-1.71M-1.10M-2.25M-5.18M-11.65M-15.77M-19.64M-23.79M-12.62M-8.34M-13.47M-13.92M-17.79M-24.64M-32.95M-8.37M-28.23M-39.27M-45.12M-39.84M-40.08M-34.55M-51.06M-89.09M-101.04M
Investing Cash Flow-1.02M965.24K33.62K-16.38K-305.77K-8.09M-17.77M8.01M18.86M16.00K-24.13K-7.54M-7.17M-4.77M481.00K3.40M-8.00K-69.11M-13.62M15.74M9.05M-69.46M52.65M-57.12M-39.94M-18.44M
Financing Cash Flow3.58M442.46K1.01M6.39M14.29M21.34M44.89M441.62K-11.42M27.68M36.60M74025.74M34.29M16.80M5.12M106.09M55.19M54.91M3.69M120.81M87.00K82.78M117.58M137.81M
Capital Expenditure3.75K16.09K2.37K16.38K305.77K237.78K172.11K127.26K64.95K028.51K411.76K266.18K46.78K147.00K165.00K8.00K495.00K141.00K148.00K3.29M57.00K9.00K296.00K25.00K22.00K
Free Cash Flow-2.15M-1.73M-1.10M-2.26M-5.48M-11.88M-15.95M-19.77M-23.85M-12.62M-8.37M-13.88M-14.19M-17.84M-24.79M-33.11M-8.38M-28.73M-39.42M-45.27M-43.13M-40.14M-34.56M-51.36M-89.11M-101.06M
Dividends Paid-----------0000000--2.12M-----
FCF to OCF100.17%100.94%100.22%100.73%105.91%102.04%101.09%100.65%100.27%100.00%100.34%103.06%101.91%100.26%100.60%100.50%100.10%101.75%100.36%100.33%108.27%100.14%100.03%100.58%100.03%100.02%
Dividend Paid to FCF-----------0.00%0.00%0.00%0.00%0.00%0.00%0.00%---4.92%-----

Earnings

Report DateMar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002May 15, 2003Aug 14, 2003Nov 12, 2003Mar 3, 2004May 12, 2004Aug 11, 2004Nov 15, 2004May 13, 2005Aug 12, 2005Nov 14, 2005Mar 16, 2006May 10, 2006Aug 9, 2006Nov 9, 2006Mar 15, 2007May 7, 2007Aug 2, 2007Nov 7, 2007Mar 13, 2008May 12, 2008Aug 11, 2008Nov 6, 2008Mar 25, 2009May 13, 2009Aug 13, 2009Nov 11, 2009Mar 16, 2010Apr 30, 2010Aug 6, 2010Nov 8, 2010Mar 10, 2011May 9, 2011Aug 8, 2011Nov 7, 2011Mar 7, 2012May 7, 2012Aug 6, 2012Nov 5, 2012Mar 19, 2013May 15, 2013Aug 5, 2013Nov 4, 2013Mar 26, 2014May 5, 2014Aug 11, 2014Oct 31, 2014Mar 24, 2015May 11, 2015Aug 12, 2015Nov 12, 2015Mar 14, 2016May 6, 2016Aug 9, 2016Nov 8, 2016Mar 6, 2017May 9, 2017Aug 9, 2017Nov 8, 2017Mar 14, 2018May 9, 2018Aug 9, 2018Nov 7, 2018Mar 13, 2019May 9, 2019Aug 8, 2019Nov 7, 2019Mar 12, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Mar 10, 2021May 13, 2021Aug 12, 2021Nov 12, 2021Mar 30, 2022May 11, 2022Aug 11, 2022Nov 10, 2022Mar 30, 2023May 15, 2023Aug 10, 2023Nov 9, 2023Mar 7, 2024May 9, 2024Aug 12, 2024Nov 12, 2024Mar 27, 2025May 7, 2025Aug 13, 2025Nov 12, 2025Mar 13, 2026May 7, 2026Aug 11, 2026Nov 11, 2026
EPS Estimate----------------105.00-105.00-105.00-105.00-134.17-135.62-101.50-116.67-116.67-116.67-99.17-105.00-113.75-140.00-------35.70-22.75-12.60-18.20-9.10-9.10-6.30----9.10-5.60-6.30-4.67-4.90-4.55-4.20-4.20-4.20-3.50-3.97-4.20-4.34-4.37-4.20-3.03-2.80-0.58-0.26-0.68-0.26-0.36-0.37-0.34-0.36-0.35-0.41-0.41-0.33-0.28-0.20-0.20-0.10-0.09-0.12-0.09-0.07-0.08-0.06-0.07-0.07-0.07-0.08-0.07-0.10-0.10-0.11-0.11-0.11-0.13-0.12-0.13-0.12-0.12-0.14-0.16
EPS Actual-270.50-382.50-302.38-997.50-95.19-85.42-83.03-40.53-48.67-36.33-35.00-28.99-50.25-69.07-92.25-105.00-105.00-52.50-105.00-367.50-122.50-87.50-105.00-105.00-122.50-105.00-122.50-122.50-140.00-145.66-61.21-71.73-39.97-24.17-33.94-27.30-9.10-10.50-9.10-11.90-9.10-4.20-6.09-6.18-4.69-5.60-8.40-6.30-3.50-4.20-4.20-4.20-4.20-3.50-4.20-4.20-4.20-4.20-4.20-3.50-2.80-0.70-0.97-0.90-0.28-0.23-0.29-0.38-0.37-0.29-0.34-0.38-0.30-0.28-0.27-0.16-0.18-0.23-0.13-0.07-0.07-0.07-0.05-0.06-0.07-0.07-0.07-0.07-0.10-0.09-0.11-0.12-0.11-0.13-0.12-0.14-0.14-0.13-0.15-0.16-
Surprise---------------0.00%0.00%50.00%0.00%-173.91%9.67%13.79%10.00%10.00%-5.00%-5.88%-16.67%-7.69%0.00%------23.53%60.00%16.67%50.00%-30.77%0.00%33.33%---38.46%-50.00%0.00%25.05%14.29%7.69%0.00%0.00%16.67%-20.00%-5.79%0.00%3.23%3.89%16.67%7.59%75.00%-67.24%-246.15%58.82%11.54%19.44%-2.70%-8.82%19.44%2.86%7.32%26.83%15.15%3.57%20.00%10.00%-130.00%-44.44%41.67%22.22%0.00%37.50%0.00%0.00%0.00%0.00%12.50%-42.86%10.00%-10.00%-9.09%0.00%-18.18%6.25%-16.67%-7.69%-8.33%-24.43%-14.29%-
Timing----------------------------------------------------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.02B
Enterprise Value886.73M
Trailing P/E0.00
Forward P/E0.41
PEG Ratio0.00
Price / Sales145272.62
Price / Book7.17
EPS-0.58
Book Value0.565
Revenue (TTM)1.00K
Gross Profit (TTM)-86.84M
EBITDA-142.70M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-105.48%
Return on Assets-50.15%
Shares Outstanding204.93M
Shares Float129.80M
Beta0.25
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 8 analystsTarget 10.94
  • Strong Buy
    4
  • Buy
    2
  • Hold
    2

Ownership Breakdown

Institutions
106.75%
Insiders
2.59%
Retail / Other
0.00%

Top Institutional Holders

  • NEA Management Company, LLC
    24.47M11.91%
  • Bain Capital Life Sciences Investors, LLC
    17.60M8.57%
  • VR Adviser, LLC
    13.74M6.69%
  • Deerfield Management Co
    13.57M6.60%
  • TCG Crossover Management, LLC
    12.36M6.02%
  • BlackRock Inc
    11.29M5.50%
  • Frazier Life Sciences Management, L.P.
    9.72M4.73%
  • Polar Capital Holdings PLC
    9.54M4.64%
  • Vanguard Capital Management, LLC
    7.78M3.79%
  • Nantahala Capital Management, LLC
    7.34M3.57%
  • State Street Corp
    6.71M3.26%
  • RTW INVESTMENTS, LLC
    5.95M2.90%
  • Marshall Wace Asset Management Ltd
    4.51M2.20%
  • Woodline Partners LP
    4.25M2.07%
  • Geode Capital Management, LLC
    3.59M1.75%
  • Spruce Street Capital LP
    3.45M1.68%

Top Fund Holders

  • Polar Capital Healthcare Opports Inc
    8.19M3.99%
  • Vanguard MStar Total Stk Mkt Idx Invest
    6.16M3.00%
  • iShares Russell 2000 ETF
    3.94M1.92%
  • State Street® SPDR® S&P® Biotech ETF
    3.37M1.64%

Stock Splits

  • Apr 28, 20171:70
  • Apr 26, 20101:25
  • Jul 26, 2000100:199